Harnessing CAR T-cell Insights to Develop Treatments for Hyperinflammatory Responses in Patients with COVID-19.

ABSTRACT: Cytokine release and macrophage activation contribute to immunopathology after SARS-CoV-2 infection. We discuss approaches to decrease the morbidity and mortality in patients with COVID-19 by repurposing existing drugs previously developed for cancer therapy.

SUBMITTER: Agarwal S 

PROVIDER: S-EPMC7249633 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature